MARCOS
GONZÁLEZ DÍAZ
Forscher in der Zeit 1993-2023
Calvary Mater Newcastle Hospital
Waratah, AustraliaPublikationen in Zusammenarbeit mit Forschern von Calvary Mater Newcastle Hospital (1)
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477